STTK Company Profile and Key Details

Short-term trend indicators are bearishly aligned (SMA20 1.69%, SMA50 2.85%, SMA200 90.68%). The stock’s 14-day RSI is 51.25 (neutral), while the ATR of 0.31 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -17.38% below its high and over 483.69% above its low. Average 10-day trading volume of 425.92 thousand shares is below the 3-month average of 476.67 thousand, indicating normal recent market interest.

Shattuck Labs, Inc. generated EPS of -$1.02 over the past year. Five-year average earnings growth is -20.93%. Wall Street analysts project EPS growth of 32.63% annually over the next five years. The latest quarter delivered EPS of -$0.12. The next quarter is forecast at -$0.14. Next year's EPS is expected at $13.28. Analyst sentiment is bullish. Analyst rating data shows there are 4 Strong Buy ratings, 2 Buy ratings, 2 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $18.00 to $2.00. The high target offers 151.75% upside. The low target suggests -72.03% downside. The mean target is $8.00. This offers 11.89% upside. Shattuck Labs, Inc. earnings surprise history is frequent misses against expectations. The quarter that ended March 05, 2026, missed forecasts by 0.0%. The prior quarter beat by -6.67%. Over the last six quarters, Apple has recorded several small beats. These include -21.9% in November 14, 2024.

Shattuck Labs, Inc. has 47.90 million shares outstanding. The public float is 23.91 million shares, elevated short interest at 3.95% of float. This equals 1.28 million shares. The short ratio is 0.29 days. Institutional investors hold 67.15% of the float. Insiders own 5.09%. Redmile Group, LLC holds 5.41 million shares, Hornblower Josiah has 2.97 million shares and Ashiya Mona has 1.05 million shares.

Shattuck Labs, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $0.49. This means the shares are trading above this model’s fair value.

Shattuck Labs, Inc. (NASDAQ:STTK) closed at $6.99 USD, losing -$0.16 (-2.24%) from the previous close of $7.15. The stock is currently mid-range between its 52-week high and low $0.71 and $8.33. With a market capitalization of about $334.84 million, Shattuck Labs, Inc. is classified as a small-cap and shows market-like volatility (beta ~1.29). Key stats such as the average daily volume over the past year has been around 531.72 thousand shares, in line with its 52-week average. Headquartered in Austin, TX, Shattuck Labs, Inc. operates in the Healthcare sector and the Biotechnology industry. Led by CEO Taylor H. Schreiber, the company employs approximately 44 people and listed since October 09, 2020. Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States.

Shattuck Labs, Inc. trades at a P/E ratio of -15.3, slightly below the S&P 500 average, with a price-to-sales ratio of 344.66 and a price-to-book ratio of 9.06 trading at moderately above to book value. The P/FCF stands at -8.63, also below market averages.

Our AI price prediction model suggests that Shattuck Labs, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 11.05%, with price expected at $7.94 by May 14, 2026, within a range of $7.71 to $8.20 3-Month Outlook: Projected fall of -52.03%, reaching $3.43 by July 29, 2026, with a range of $3.22 to $3.68. 1-Year Outlook: Projected gain of 306.99%, with price at $29.10 by April 30, 2027, within a range of $32.12 to $34.74.

Shattuck Labs, Inc. (NASDAQ:STTK) shares are up 18.9% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Shattuck Labs, Inc. trading at a premium to the broader market with a P/E of -15.3. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $15.22, suggesting 112.87% upside. Our AI forecast model points to short-term strength (11.05% over two weeks), a medium-term fall (-52.03% over three months), and a longer-term gain (306.99% over one year), with expected trading ranges indicating moderate volatility.